Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Essex Capital Arranges $95 Million Acquisition Recapitalization

Essex Capital Group,Inc.
Posted on: 15 Nov 18
Essex Capital Arranges $95 Million Acquisition Recapitalization

PR Newswire

TAMPA, Fla., Nov. 15, 2018

TAMPA, Fla., Nov. 15, 2018 /PRNewswire/ -- Essex Capital Group, Inc. ("Essex"), announced today that the firm recently arranged a $95,000,000 acquisition financing and recapitalization for CAN Community Health, Inc. ("CAN" or the "Company"), a private, not-for-profit organization dedicated to the treatment, care and continual wellness of people living with HIV, hepatitis C, STDs and other diseases. The Company has been serving the needs of the HIV community in Florida and the Southeast US since 1991.  CAN currently operates 34 medical clinics, offering medical, dental, psychological and lifestyle counseling to all patients, regardless of their financial situation, insurance status, or ability to pay.

As a part of this transaction, Essex structured and negotiated two separate specialty pharmacy company acquisitions on behalf of CAN, subsequently arranging a comprehensive acquisition term debt financing solution.

The financing structure also provided a $30 million merchant card program to fund the tremendous organic growth currently being experienced by the Company.

Richard E. Carlisle, CAN CEO commented: "We recognized an opportunity to vertically integrate our business through two pharmacy acquisitions. In hiring an investment banking firm to negotiate, structure and finance these transactions, we interviewed several firms. After a detailed review of available options, we chose to hire Essex Capital Group to lead the process."

"Working closely with Rob and Bob over the last 6 months was a pleasure. They delivered on what they said they would do, and they exceeded my expectations in the level of professionalism, deal structuring creativity and tenacity displayed in getting a complicated transaction completed. We now consider Essex a vital business partner as we move forward with other growth opportunities."

Essex Capital acted as the Company's exclusive financial advisor in this transaction.

Robert Swain
President
Essex Capital Group, Inc.
8138373500
rob@essexcapitalgroup.com

This release was issued through WebWire®. For more information, visit http://www.webwire.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/essex-capital-arranges-95-million-acquisition-recapitalization-300750948.html

SOURCE Essex Capital Group, Inc.

PR Newswire
www.prnewswire.com

Last updated on: 15/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.